INS and Alzheimer disease: As it was previously mentioned, the bioavailability and downstream actions of insulin in the brain can be diminished in the context of MCI, dementia and particularly in AD, supporting the concept of the disease as “Type 3 Diabetes.” The administration of insulin in the context of diabetes is a well-known treatment.